These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8282084)

  • 41. Skeletal muscle proteins rescue motor neurons from cell death in vivo.
    McManaman JL; Haverkamp LJ; Oppenheim RW
    Adv Neurol; 1991; 56():81-8. PubMed ID: 1853784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor system in amyotrophic lateral sclerosis.
    Wilczak N; Keyser J
    Endocr Dev; 2005; 9():160-169. PubMed ID: 15879696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice.
    Narai H; Nagano I; Ilieva H; Shiote M; Nagata T; Hayashi T; Shoji M; Abe K
    J Neurosci Res; 2005 Nov; 82(4):452-7. PubMed ID: 16235250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor 1-induced alterations in lumbospinal monoamine dynamics.
    Bitar MS; Francis IM; Pilcher CW
    Horm Metab Res; 2000 Jun; 32(6):207-15. PubMed ID: 10898549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotrophic factor therapy for nervous system degenerative diseases.
    Hefti F
    J Neurobiol; 1994 Nov; 25(11):1418-35. PubMed ID: 7852995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor neuron diseases in man and animals.
    Duchen LW
    Invest Cell Pathol; 1978; 1(3):249-62. PubMed ID: 93105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trophic effect of olmesartan, a novel AT1R antagonist, on spinal motor neurons in vitro and in vivo.
    Iwasaki Y; Ichikawa Y; Igarashi O; Kinoshita M; Ikeda K
    Neurol Res; 2002 Jul; 24(5):468-72. PubMed ID: 12117316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotrophic factors in the treatment of motor neuron disease and trauma.
    DiStefano PS
    Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves.
    Yuen EC; Mobley WC
    Mol Med Today; 1995 Sep; 1(6):278-86. PubMed ID: 9415162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.
    Appel SH
    Ann Neurol; 1981 Dec; 10(6):499-505. PubMed ID: 6173010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.
    Saenger S; Goeldner C; Frey JR; Ozmen L; Ostrowitzki S; Spooren W; Ballard TM; Prinssen E; Borroni E; Metzger F
    Growth Horm IGF Res; 2011 Oct; 21(5):292-303. PubMed ID: 21865068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.
    Di Giulio AM; Germani E; Lesma E; Muller E; Gorio A
    Int J Dev Neurosci; 2000; 18(4-5):339-46. PubMed ID: 10817918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications.
    Thoenen H; Hughes RA; Sendtner M
    Exp Neurol; 1993 Nov; 124(1):47-55. PubMed ID: 8282079
    [No Abstract]   [Full Text] [Related]  

  • 54. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease.
    Hantaï D; Akaaboune M; Lagord C; Murawsky M; Houenou LJ; Festoff BW; Vaught JL; Rieger F; Blondet B
    J Neurol Sci; 1995 May; 129 Suppl():122-6. PubMed ID: 7595602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotrophic and Neuroregenerative Effects of GH/IGF1.
    Bianchi VE; Locatelli V; Rizzi L
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis.
    Adem A; Ekblom J; Gillberg PG; Jossan SS; Höög A; Winblad B; Aquilonius SM; Wang LH; Sara V
    J Neural Transm Gen Sect; 1994; 97(1):73-84. PubMed ID: 7888151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factors in the peripheral nervous system.
    Sakowski SA; Feldman EL
    Endocrinol Metab Clin North Am; 2012 Jun; 41(2):375-93, vii. PubMed ID: 22682636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Will ciliary neurotrophic factor slow progression of motor neuron disease?
    Longo FM
    Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression.
    Osborn TM; Beagan J; Isacson O
    Neurobiol Dis; 2018 Feb; 110():218-230. PubMed ID: 29113829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effect of interleukin-3 and erythropoietin on motor neuron death after neonatal axotomy.
    Iwasaki Y; Ikeda K; Ichikawa Y; Igarashi O; Iwamoto K; Kinoshita M
    Neurol Res; 2002 Oct; 24(7):643-6. PubMed ID: 12392198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.